New Product Development
Over the forecast period, the global Gait Trainer Market is expected to grow at a moderate CAGR of 4.9%. According to the most recent industry analysis by Future Market Insights, the market will be worth US$ 342.7 million in 2022 and will be worth US$ 456.3 million by the end of 2028. A rapidly growing …
Continue reading “Gait Trainer Market to Etch New Growth Ratio with Adoption in Developing Economy”
The global market for anti-microbial/anti-fungal tests is expected to reach US$ 2.5 billion by the end of 2022. The market is expected to grow at a CAGR of 5.7% and surpass US$ 4.5 billion by 2032. In terms of test type, molecular-based tests led the market in 2021, accounting for nearly 53.5% of the market. …
The global chronic refractory cough treatment market is expected to be worth USD 9.2 billion in 2023 and USD 17.1 billion by 2033, growing at a CAGR of 6.39%. The global prevalence of refractory chronic cough is driving the market for refractory chronic cough therapeutics. Increased global healthcare spending and disease awareness would expand the …
The global diamond-blackfan anaemia (DBAAASE) syndrome therapeutics market is expected to exceed a valuation of US$ 4.8 billion in 2023, with a CAGR of 4.2% from 2023 to 2033. By the end of the aforementioned assessment period, the market is expected to be valued at US$ 7.29 billion. Diamond-blackfan anaemia is an inherited blood disorder …
The global Dengue Fever Treatment Market is expected to generate a market value of US$ 877.82 Million in 2023 and a market value of US$ 5435.25 Million by 2023, with a CAGR of 20% from 2023 to 2033. From 2018 to 2022, the market for Dengue Fever Treatment grew at an 11% CAGR. According to …
The global coxsackievirus infections treatment market is currently worth US$ 5.5 billion in 2023 and is expected to grow at an 8.2% CAGR. Because of technological advancements in healthcare, the market is expected to reach $12.1 billion by 2033. Increased demand for improved healthcare infrastructure, as well as an increasing incidence rate, are expected to …
The global chronic Granulomatous disease (CGD) management market is expected to generate a market value of US$ 1.31 billion in 2023 and a market value of US$ 2.11 billion by 2033, with a CAGR of 4.9% from 2023 to 2033. The increasing research and development activities of key players for developing medications can be attributed …
The global anorectal malformation treatment market is expected to surpass an impressive valuation of US$ 794.91 million in 2023 and to grow at a 7.4% CAGR from 2023 to 2033, reaching US$ 4 1,475.19 million. Boys are slightly more likely than girls to have anorectal malformations. Anorectal malformations are deformities of a baby’s anus or …
Continue reading “Anorectal Malformation Treatment Market to expand at a 7% value CAGR by 2033”
[311 Pages Report] According to a recent study done by FMI, the ePharmacy market is expected to reach US$ 329.83 billion by 2032, up from US$ 69.8 billion in 2021, expanding at a high CAGR of 16.5%. This study explains how the ePharmacy market is directly proportional to the increasing penetration of internet-based pharmacy in the world market coupled …
[314 Pages Report] According to a recent study by Future Market Insights (FMI), the global dry eye syndrome market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 4.52 Bn in 2021 to around US$ 8.84 Bn by 2031. This reflects a cumulative CAGR of around 7.0% over the forecast period (2022-2031). Dry eye syndrome …
